DXCM DEXCOM INC
2026Q2 · CUSIP 252131107 · Sector: Healthcare & Biotech
Funds are exiting, but the price is holding
951 funds held DXCM at the end of 2026Q2, down 8 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $5.0B(YoY +15.5%), the P/E is 36.1x, return on equity is 38.1%. DXCM has had 26 buying rushes in its history, and the price moved +1.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.
How many funds owned it, quarter by quarter
Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.
What happened after each past buying rush 26 times in its history
| Quarter of the rush | How unusual then | Price, next 3 months | Price, next 6 months |
|---|---|---|---|
| 2026Q1 | Top 10% | — | — |
| 2024Q4 | Top 10% | -4.0% | -9.3% |
| 2024Q1 | Top 5% | -40.9% | -42.2% |
| 2023Q4 | Top 10% | +12.2% | -33.6% |
| 2023Q2 | Top 5% | -8.8% | +5.9% |
| 2022Q4 | Top 5% | +1.5% | -9.6% |
| 2021Q4 | Top 5% | -25.4% | -15.4% |
| 2021Q3 | Top 1% in the market | -40.5% | -51.5% |
These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.
Show all the numbers (large funds, value held, options…) ▾ Collapse ▴
These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.
8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.
Fundamentals
Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable
P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden
FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden
As of 2026-06-30 · SEC filings (XBRL)
Email me the next update
2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.